LEXARIA CORP. - SCHEDULE 13D

Company

Lexaria Bioscience Corp.

Filed

February 8, 2010

Accession Number

0001137171-10-000081

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →